transplant rejection
Natera Prospera Lung Test Receives Medicare Coverage for Single Lung Transplant Patients
The test was launched in 2022 and received coverage for double-lung transplant patients in 2023.
CareDx Raises Full-Year Guidance as Q3 Revenues Grow 23 Percent
Quarterly revenue gains were driven by a 27 percent year-over-year increase in testing services revenue.
Dovetail Genomics, CareDx Partner on HLA Genotyping for Transplant Matching
The firms will launch an early-access program for CareDx's NGS-based AlloSeq Tx 17 HLA typing assay, which incorporates Dovetail's LinkPrep NGS technology.
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test
The company intends to use the funds for general corporate purposes as it seeks to gain customers and regulatory support for its GraftAssure transplant rejection test.
MolDx Backs off Proposed LCD for Solid Organ Allograft Rejection Testing
Medicare administrative contractors plan to propose a new LCD in the coming months. Meanwhile, the existing coverage criteria remains.
Jan 3, 2024
Nov 22, 2023
Nov 9, 2023
May 10, 2023